The predominance of NKG2A+ NK cells in the tumor microenvironment reveals its importance in the suppressive axis between tumor and NK cells [68], leading to important clinical studies using anti-NKG2A inhibitory antibodies in the treatment of cancer [69,70]. Here, KLRC1 is linked to neoplasm.